GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (STU:L74) » Definitions » Buyback Yield %

WuXi XDC Cayman (STU:L74) Buyback Yield % : 0.00 (As of Mar. 29, 2025)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

WuXi XDC Cayman's current buyback yield was 0.00%.

WuXi XDC Cayman Buyback Yield % Historical Data

The historical data trend for WuXi XDC Cayman's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Buyback Yield % Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Buyback Yield %
- - - -10.71 -

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Buyback Yield % Get a 7-Day Free Trial - - -10.29 - -

Competitive Comparison of WuXi XDC Cayman's Buyback Yield %

For the Diagnostics & Research subindustry, WuXi XDC Cayman's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi XDC Cayman's Buyback Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's Buyback Yield % falls into.


;
;

WuXi XDC Cayman Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

WuXi XDC Cayman's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 462.849) / 4320.95884
=-10.71%

WuXi XDC Cayman's annualized Buyback Yield for the quarter that ended in Jun. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.105) / 2420.3943
=-0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

WuXi XDC Cayman Buyback Yield % Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (STU:L74) » Definitions » Buyback Yield %
Comparable Companies
HKSE:09860 HKSE:02325 HKSE:06667 HKSE:09960 HKSE:08037 HKSE:02427 HKSE:08225 HKSE:08247 HKSE:00928 TMO DHR XSWX:LONN A IDXX IQV SHSE:603259 MTD WAT NTRA LH
Traded in Other Exchanges
02268:Hong Kong
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
Website
https://www.wuxixdc.com
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman Headlines

No Headlines